Ngā hua rapu - Torsten Haack
- E whakaatu ana i te 1 - 3 hua o te 3
-
1
A novel dual glucagon‐like peptide and glucagon receptor agonist SAR425899: Results of randomized, placebo‐controlled first‐in‐human and first‐in‐patient trials mā J. Tillner, Maximilian Posch, Frank Wagner, Lenore Teichert, Youssef Hijazi, Christine Einig, Stefanie Keil, Torsten Haack, Michael Wagner, Martin Bossart, Philip J. Larsen
I whakaputaina 2018Artigo -
2
Receptor occupancy of dual glucagon-like peptide 1/glucagon receptor agonist SAR425899 in individuals with type 2 diabetes mā Olof Eriksson, Torsten Haack, Youssef Hijazi, Lenore Teichert, Veronique Tavernier, Iina Laitinen, Jan Erik Berglund, Gunnar Antoni, Irina Velikyan, L. E. B. Johansson, Stefan Pierrou, Michael Wagner, J. Tillner
I whakaputaina 2020Artigo -
3
Conformational Control Inhibition of the BCR-ABL1 Tyrosine Kinase, Including the Gatekeeper T315I Mutant, by the Switch-Control Inhibitor DCC-2036 mā Wayne W. Chan, Scott Wise, Michael D. Kaufman, Yu Mi Ahn, Carol L. Ensinger, Torsten Haack, Molly M. Hood, Jennifer Jones, John Lord, Wei Lu, David F. Miller, William C. Patt, Bryan D. Smith, Peter A. Petillo, Thomas J. Rutkoski, Hanumaiah Telikepalli, Lakshminarayana Vogeti, Tony Yao, Lawrence Chun, Robin Clark, Peter Evangelista, L. Cristina Gavrilescu, Katherine Lazarides, Virginia M. Zaleskas, Lance J. Stewart, Richard A. Van Etten, Daniel L. Flynn
I whakaputaina 2011Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Agonist
Biology
Chemistry
Diabetes mellitus
Endocrinology
Glucagon
Glucagon-like peptide 1 receptor
Insulin
Internal medicine
Medicine
Receptor
Type 2 diabetes
ABL
Adverse effect
Alternative medicine
Biochemistry
Body mass index
Cancer
Cancer research
Cell biology
Dasatinib
Ecology
Gastroenterology
Gene
Genetics
Glucagon receptor
Hypoglycemia
Imatinib
Immunology
K562 cells